Browsing Wolfson Institute of Preventive Medicine by Author "Whelan, TJ"
Now showing items 1-6 of 6
-
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (vol 28, pg 1700, 2017)
Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2019-07) -
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (vol 28, pg 1700, 2017)
Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2018-10) -
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Curigliano, G; Burstein, HJ; P Winer, E; Gnant, M; Dubsky, P; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2017-08-01)The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna, Austria reviewed substantial new evidence on loco-regional and systemic therapies for early breast cancer. Treatments were assessed in light of ... -
Reply to 'The St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology' by Kirova et al.
Dubsky, P; Curigliano, G; Burstein, HJ; Winer, EP; Gnant, M; Loibl, S; Colleoni, M; Regan, MM; Piccart-Gebhart, M; Senn, H-J (2018-01) -
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations.
Dowling, RJO; Kalinsky, K; Hayes, DF; Bidard, F-C; Cescon, DW; Chandarlapaty, S; Deasy, JO; Dowsett, M; Gray, RJ; Henry, NL (2019-12)Disease recurrence (locoregional, distant) exerts a significant clinical impact on the survival of estrogen receptor-positive breast cancer patients. Many of these recurrences occur late, more than 5 years after original ... -
Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions.
Dowling, RJO; Sparano, JA; Goodwin, PJ; Bidard, F-C; Cescon, DW; Chandarlapaty, S; Deasy, JO; Dowsett, M; Gray, RJ; Henry, NL (2019-12)Late disease recurrence (more than 5 years after initial diagnosis) represents a clinical challenge in the treatment and management of estrogen receptor-positive breast cancer (BC). An international workshop was convened ...